Integra LifeSciences Holdings Corporation (NASDAQ:IART) (TREND ANALYSIS) shares were traded with no significant volume change. The stock closed last trading session at $61.34, up by 1.47%, with a volume of 109,506 shares against an average volume for the last 30 days of 167,744.
IART reported last quarter earnings figures on February 24th. The company announced actual earnings per share of $0.94 against the consensus Street estimate of $0.89. This represents a year-on-year increase of earning per share of $0.16 from corresponding quarter of last year. Integra LifeSciences Holdings Corporation posted revenue of $252.18 million.
The company is currently valued at $2.01 billion and closed the last trading session at $61.34. The stock has 50-day moving average of $59.05 and a 200-day moving average of $52.04.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) is currently trading 2.63% below its 52-week-high, 44.32% above its 52-week-low and in the range of $57.78-$63 over the past month. The 1-year range for the stock is $42.5-$63. Integra LifeSciences Holdings Corporation (IART) has a price to book ratio of 2.85 versus Nasdaq average of 4.67. The company’s share price has outperformed the Nasdaq year to date by over 11.86%.
Integra LifeSciences Holdings Corporation (IART) current short interest stands at 2,513,200 shares. It has increased by 29% from the same period of last month. Around 9.9% of the company’s shares, which are float, are short sold. With a 30-days average daily volume of 167,744 shares, the number of days required to cover the short positions stand at 15.5 days.
